Sara M. Weis, Ph.D. - Publications

Affiliations: 
2000 University of California, San Diego, La Jolla, CA 
Area:
Biomedical Engineering

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Franovic A, Elliott KC, Seguin L, Camargo MF, Weis SM, Cheresh DA. Glioblastomas Require Integrin αvβ3/PAK4 Signaling to Escape Senescence. Cancer Research. 75: 4466-73. PMID 26297735 DOI: 10.1158/0008-5472.CAN-15-0988  1
2015 Seguin L, Desgrosellier JS, Weis SM, Cheresh DA. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends in Cell Biology. 25: 234-40. PMID 25572304 DOI: 10.1016/j.tcb.2014.12.006  1
2015 Advani SJ, Camargo MF, Seguin L, Mielgo A, Anand S, Hicks AM, Aguilera J, Franovic A, Weis SM, Cheresh DA. Kinase-independent role for CRAF-driving tumour radioresistance via CHK2 Nature Communications. 6. DOI: 10.1038/ncomms9154  1
2014 Seguin L, Gozo M, Weis SM, Cheresh DA. Targeting the Achilles' heel of drug-resistant cancer stem cells. Cell Cycle (Georgetown, Tex.). 13: 2017-8. PMID 24906000 DOI: 10.4161/cc.29460  1
2014 Seguin L, Weis SM, Cheresh DA. Variety in the tumor microenvironment: integrin splicing regulates stemness. Cell Stem Cell. 14: 557-8. PMID 24792112 DOI: 10.1016/j.stem.2014.04.011  1
2014 Seguin L, Kato S, Franovic A, Camargo MF, Lesperance J, Elliott KC, Yebra M, Mielgo A, Lowy AM, Husain H, Cascone T, Diao L, Wang J, Wistuba II, Heymach JV, ... ... Weis SM, et al. An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition. Nature Cell Biology. 16: 457-68. PMID 24747441 DOI: 10.1038/ncb2953  1
2014 Jean C, Chen XL, Nam JO, Tancioni I, Uryu S, Lawson C, Ward KK, Walsh CT, Miller NL, Ghassemian M, Turowski P, Dejana E, Weis S, Cheresh DA, Schlaepfer DD. Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function. The Journal of Cell Biology. 204: 247-63. PMID 24446483 DOI: 10.1083/jcb.201307067  1
2013 Weis SM, Cheresh DA. A wake-up call for hibernating tumour cells. Nature Cell Biology. 15: 721-3. PMID 23817234 DOI: 10.1038/ncb2794  1
2012 Lim ST, Miller NL, Chen XL, Tancioni I, Walsh CT, Lawson C, Uryu S, Weis SM, Cheresh DA, Schlaepfer DD. Nuclear-localized focal adhesion kinase regulates inflammatory VCAM-1 expression. The Journal of Cell Biology. 197: 907-19. PMID 22734001 DOI: 10.1083/jcb.201109067  1
2012 Lau SK, Shields DJ, Murphy EA, Desgrosellier JS, Anand S, Huang M, Kato S, Lim ST, Weis SM, Stupack DG, Schlaepfer DD, Cheresh DA. EGFR-mediated carcinoma cell metastasis mediated by integrin αvβ5 depends on activation of c-Src and cleavage of MUC1. Plos One. 7: e36753. PMID 22586492 DOI: 10.1371/journal.pone.0036753  1
2012 Chen XL, Nam JO, Jean C, Lawson C, Walsh CT, Goka E, Lim ST, Tomar A, Tancioni I, Uryu S, Guan JL, Acevedo LM, Weis SM, Cheresh DA, Schlaepfer DD. VEGF-induced vascular permeability is mediated by FAK. Developmental Cell. 22: 146-57. PMID 22264731 DOI: 10.1016/j.devcel.2011.11.002  1
2012 Scheppke L, Murphy EA, Zarpellon A, Hofmann JJ, Merkulova A, Shields DJ, Weis SM, Byzova TV, Ruggeri ZM, Iruela-Arispe ML, Cheresh DA. Notch promotes vascular maturation by inducing integrin-mediated smooth muscle cell adhesion to the endothelial basement membrane. Blood. 119: 2149-58. PMID 22134168 DOI: 10.1182/blood-2011-04-348706  1
2011 Weis SM, Cheresh DA. αV integrins in angiogenesis and cancer. Cold Spring Harbor Perspectives in Medicine. 1: a006478. PMID 22229119 DOI: 10.1101/cshperspect.a006478  1
2011 Mielgo A, Seguin L, Huang M, Camargo MF, Anand S, Franovic A, Weis SM, Advani SJ, Murphy EA, Cheresh DA. A MEK-independent role for CRAF in mitosis and tumor progression. Nature Medicine. 17: 1641-5. PMID 22081024 DOI: 10.1038/nm.2464  1
2011 Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets. Nature Medicine. 17: 1359-70. PMID 22064426 DOI: 10.1038/nm.2537  1
2011 Weis SM. Evaluation of VEGF-induced vascular permeability in mice. Methods in Molecular Biology (Clifton, N.J.). 763: 403-15. PMID 21874467 DOI: 10.1007/978-1-61779-191-8_27  1
2011 Aspinall RJ, Weis SM, Barnes L, Lutu-Fuga K, Bylund DJ, Pockros PJ, Cheresh DA. A Src family kinase inhibitor improves survival in experimental acute liver failure associated with elevated cerebral and circulating vascular endothelial growth factor levels. Liver International : Official Journal of the International Association For the Study of the Liver. 31: 1222-30. PMID 21745297 DOI: 10.1111/j.1478-3231.2011.02554.x  1
2010 Anand S, Majeti BK, Acevedo LM, Murphy EA, Mukthavaram R, Scheppke L, Huang M, Shields DJ, Lindquist JN, Lapinski PE, King PD, Weis SM, Cheresh DA. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nature Medicine. 16: 909-14. PMID 20676106 DOI: 10.1038/nm.2186  1
2009 Weis SM, Stupack DG, Cheresh DA. Agonizing integrin antagonists? Cancer Cell. 15: 359-61. PMID 19411065 DOI: 10.1016/j.ccr.2009.04.005  1
2009 Ricono JM, Huang M, Barnes LA, Lau SK, Weis SM, Schlaepfer DD, Hanks SK, Cheresh DA. Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis. Cancer Research. 69: 1383-91. PMID 19208836 DOI: 10.1158/0008-5472.CAN-08-3612  1
2008 Weis SM. Chapter 5. Evaluating vascular leak in vivo. Methods in Enzymology. 444: 99-114. PMID 19007662 DOI: 10.1016/S0076-6879(08)02805-X  1
2008 Murphy EA, Majeti BK, Barnes LA, Makale M, Weis SM, Lutu-Fuga K, Wrasidlo W, Cheresh DA. Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis. Proceedings of the National Academy of Sciences of the United States of America. 105: 9343-8. PMID 18607000 DOI: 10.1073/pnas.0803728105  1
2008 Acevedo LM, Weis SM, Cheresh DA. Robo4 counteracts VEGF signaling. Nature Medicine. 14: 372-3. PMID 18391935 DOI: 10.1038/nm0408-372  1
2008 Weis SM. Vascular permeability in cardiovascular disease and cancer. Current Opinion in Hematology. 15: 243-9. PMID 18391792 DOI: 10.1097/MOH.0b013e3282f97d86  1
2008 Weis SM, Lim ST, Lutu-Fuga KM, Barnes LA, Chen XL, Göthert JR, Shen TL, Guan JL, Schlaepfer DD, Cheresh DA. Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK. The Journal of Cell Biology. 181: 43-50. PMID 18391070 DOI: 10.1083/jcb.200710038  1
2008 Acevedo LM, Barillas S, Weis SM, Göthert JR, Cheresh DA. Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood. 111: 2674-80. PMID 18180379 DOI: 10.1182/blood-2007-08-110205  1
2007 Weis SM. Evaluating integrin function in models of angiogenesis and vascular permeability. Methods in Enzymology. 426: 505-28. PMID 17697897 DOI: 10.1016/S0076-6879(07)26021-5  1
2007 Weis SM, Lindquist JN, Barnes LA, Lutu-Fuga KM, Cui J, Wood MR, Cheresh DA. Cooperation between VEGF and beta3 integrin during cardiac vascular development. Blood. 109: 1962-70. PMID 17062734 DOI: 10.1182/blood-2005-10-038893  1
2005 Weis SM, Cheresh DA. Pathophysiological consequences of VEGF-induced vascular permeability. Nature. 437: 497-504. PMID 16177780 DOI: 10.1038/nature03987  1
2005 Weis SM, Zimmerman SD, Shah M, Covell JW, Omens JH, Ross J, Dalton N, Jones Y, Reed CC, Iozzo RV, McCulloch AD. A role for decorin in the remodeling of myocardial infarction. Matrix Biology : Journal of the International Society For Matrix Biology. 24: 313-24. PMID 15949932 DOI: 10.1016/j.matbio.2005.05.003  1
2001 Gregersen H, Weis SM, McCulloch AD. Oesophageal morphometry and residual strain in a mouse model of osteogenesis imperfecta. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 13: 457-64. PMID 11696107 DOI: 10.1046/j.1365-2982.2001.00279.x  1
2000 Weis SM, Emery JL, Becker KD, McBride DJ, Omens JH, McCulloch AD. Myocardial mechanics and collagen structure in the osteogenesis imperfecta murine (oim). Circulation Research. 87: 663-9. PMID 11029401  1
Show low-probability matches.